Table 1.
What patients? | Justification | Advantages | Risks | Needs for IC beds | |
---|---|---|---|---|---|
Strategy 1 ‘Benefit outweighs risk’ |
Operate on patients whose need is high | Deterioration in health very probable within 6 months | Very high benefit if post-operative effects are simple | Some of these patients have the highest risk of complications | High |
Strategy 2 ‘Safe and preventive’ |
Operate on patients with the least possible comorbidities | Reduces the number of patients with obesity on waiting lists for weight-loss surgery, so reducing the number of vulnerable patients | Benefits high but less than in Strategy 1 | Patients are less at risk This strategy is not very realistic |
Rare |
Strategy 3 ‘SOFFCO guidelines’ |
Operate on patients whose need is high provided the risk of morbidity is very low | 1/This metabolic surgery is the only effective treatement for obesity 2/Mitigates excess mortality linked to obesity |
1/Very favourable benefit/risk ratio at both individual and public health scales 2/Reduction of comorbidities linked to obesity with less operating risk |
Low | Rare |